Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - - Sutro has selected PTK7 as the target for its initial dual-payload candidate, STRO-227 - - Investor ...

According to Towards Packaging consultants, the U.S. 503B compounding pharmacy packaging market is expected to witness substantial growth through 2034, expanding steadily over the forecast ...